Cas:69981-34-6 (2R)-2-amino-N-tert-butyl-3-methylbutanamide manufacturer & supplier

Chemical Name:(2R)-2-amino-N-tert-butyl-3-methylbutanamide

CAS.NO:69981-34-6

Synonyms:BUTANAMIDE,2-AMINO-N-(1,1-DIMETHYLETHYL)-3-METHYL-,(2R);H-L-Val-NHtBu;(S)-2-amino-N-tert-butyl-3-methylbutanamide;(R)-2-amino-N-tert-butyl-3-methylbutanamide;(2R)-2-azanyl-N-tert-butyl-3-methyl-butanamide;H-Val-NHBu-t;(S)-Val-tert-butylamide;L-valine-tert-butylamide;H-Val-NH-t-Bu

Molecular Formula:C₉H₂₀N₂O

Molecular Weight:172.26800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:0.918

Index of Refraction:

PSA:58.61000

Exact Mass:172.15800

LogP:2.42500

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like BUTANAMIDE,2-AMINO-N-(1,1-DIMETHYLETHYL)-3-METHYL-,(2R) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,H-Val-NH-t-Bu physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-Val-tert-butylamide Use and application,BUTANAMIDE,2-AMINO-N-(1,1-DIMETHYLETHYL)-3-METHYL-,(2R) technical grade,usp/ep/jp grade.

Related News: The announcement comes on top of Recipharm’s move into Morocco, which was fueled by local pledges of $500 million. The new facility under construction and due for completion in 2023 will employ 300 and have a capacity of 300 million units annually. Oxidase, cytochrome (Asellus aquaticus strain VR1mitochondria-encoded gene COI subunit I fragment) manufacturers The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients. 2-[(2-phenylcyclohexyl)amino]acetic acid suppliers Bluebird determined that death was highly unlikely to have been caused by the delivery virus used in both Zynteglo and LentiGlobin. 4-amino-2-(methylamino)-4-oxobutanoic acid vendor & factory By integrating biocatalysis into ongoing and newly launched projects, Wavelength Pharmaceuticals has shown that it is possible to reduce overall costs by as much as 30%.,The announcement comes on top of Recipharm’s move into Morocco, which was fueled by local pledges of $500 million. The new facility under construction and due for completion in 2023 will employ 300 and have a capacity of 300 million units annually.